Clal Biotechnology reported ILS-0.04 in EPS Earnings Per Share for its fiscal quarter ending in December of 2022.


Eps Change Date
Clal Biotechnology ILS -0.04 0.1 Dec/2022
Compugen USD -0.08 0.01 Jun/2025
Life Technologies USD -0.22 0.04 Jun/2025
RedHill Biopharma USD -1.31 33.38 Jun/2024